Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug – CNBC

Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug  CNBC

Leave a Reply

Your email address will not be published. Required fields are marked *